The landscape of metabolic and endocrinology research has been fundamentally transformed over the past decade by the emergence of Glucagon-Like Peptide-1 (GLP-1) receptor agonists. In laboratory settings, these synthetic peptides have demonstrated unprecedented efficacy in modulating glucose metabolism, gastric emptying, and neurological reward pathways. For researchers studying metabolic syndrome, obesity models, and cellular energy regulation, […]
